2020-10-13 14:59:00
On the occasion of World Antibiotic Information Day and European Antibiotic Resistance Day, ANSES is organizing a scientific meeting on the morning of November 18 on the theme of antibiotic resistance.
During this event, which will be held in digital format taking into account the health context, ANSES will take stock of the most recent developments concerning antibiotic resistance observed in animals (Résapath report) and the sales of antibiotics in veterinary medicine. . The Agency, as the national reference laboratory for antimicrobial resistance, will also present the results of the European surveillance plan.
At the end of the morning, the presentation of the ANSES opinion on environmental antibiotic resistance will present the conclusions of this scientific expertise, with new insights into the contamination of environments by antibiotics and resistant and pathogenic bacteria. understanding the mechanisms behind the development of antibiotic resistance in the latter.
This scientific meeting is part of the implementation of the interministerial roadmap adopted on November 18, 2016, which aims to strengthen and coordinate efforts to fight more effectively against antibiotic resistance in the human and non-human sectors. Through this meeting, ANSES wishes to contribute to the information and mobilization of the stakeholders concerned, whether they are scientists, decision-makers or professionals in the field, around this issue, in order to explore new actions to improve the use of antibiotics in veterinary medicine and limit their impacts.
This webinar was held only in French.
Wednesday November 18, 2020 from 10 a.m. to 12 p.m.
1730507007
#ANSES #scientific #meetings #Antibiotic #resistance #animal #health #environment #Handles
**Interview with Dr. Marie Dupont, Antimicrobial Resistance Expert**
**Interviewer:** Dr. Dupont, thank you for joining us. On November 18, ANSES will host a scientific meeting focusing on antibiotic resistance in animals. How significant is the role of veterinary practices in addressing the growing crisis of antimicrobial resistance?
**Dr. Dupont:** Thank you for having me. The role of veterinary practices is crucial. Antibiotics used in livestock can contribute to the emergence of resistant bacteria, which can then transfer to humans through the food chain or environmental contamination. It’s essential that we understand and improve antibiotic usage in animals to mitigate these risks.
**Interviewer:** Many experts are advocating for stricter regulations on antibiotic use in agriculture. What are some of the potential downsides of such regulations?
**Dr. Dupont:** While stricter regulations are necessary, they could also lead to challenges such as increased production costs for farmers, potential shortages of effective treatments for animal diseases, and concerns about animal welfare. Balancing effective antibiotic use while ensuring food security and animal health is key.
**Interviewer:** The theme of environmental contamination was highlighted in ANSES’s recent assessment. What are your thoughts on how environmental factors contribute to antibiotic resistance?
**Dr. Dupont:** Environmental contamination plays a significant role in this issue. Antibiotics and resistant bacteria can enter ecosystems through agricultural runoff, wastewater, and even through the air. This contamination can perpetuate the cycle of resistance in both human and animal populations. It’s a complex problem that requires a multipronged approach.
**Interviewer:** With increasing awareness around this issue, how can we engage the public in a meaningful way to encourage responsible antibiotic use?
**Dr. Dupont:** Education is vital. We need to raise public awareness about the consequences of antibiotic misuse and the importance of responsible practices across all sectors—human and veterinary medicine alike. Engaging in community discussions, educational campaigns, and rallying support for policy changes can empower individuals to make informed choices.
**Interviewer:** Lastly, what would you like to see as a result of the upcoming meeting on November 18?
**Dr. Dupont:** I hope it sparks a proactive dialogue among stakeholders—scientists, policymakers, practitioners—to foster collaboration and innovation. We need to develop actionable strategies to limit antibiotic use while promoting alternatives in both human and animal health.
**Interviewer:** Thank you, Dr. Dupont. Your insights highlight an urgent discussion about antibiotic resistance.
**Debate Question for Readers:** Given the complexities of regulating antibiotic use in veterinary medicine, do you think the potential benefits outweigh the drawbacks, or do you believe there are more effective solutions that should be explored instead?
